德維特 DVA 深 滬
等待開盤 09-24 09:30:00 美东时间
183.14
-0.580
-0.32%
華盛通- 最 高186.23
- 今 開184.03
- 成交量 54.43万股
- 最 低 182.48
- 昨 收 183.72
- 總市值 1168.43万
- 52周最高 247.49
- 市盈率 靜 19.25
- 換手率 853.09%
- 52周最低 101.00
- 委 比 83.33%
- 總股本 6.38万
- 歷史最高 247.49
- 量 比 0.52
- 振 幅 2.04%
- 歷史最低 43.40
- 每 手 1
- 風險率 38.91%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多Veeva Systems gains new top 20 biopharma win for Vault CRM
Veeva Systems (VEEV) traded higher on Wednesday after announcing that one of the top 20 biopharma companies has chosen Vault CRM, its customer relationship management platform. According to the Pleasa...
今天 00:19
Viatris, Teva initiated at Outperform at Oppenheimer
Oppenheimer began coverage of Viatris (VTRS) and Teva Pharmaceutical Industries (TEVA) with Outperform ratings for both. The price target for Viatris is $25 (~46% upside based on Sept. 22 close), whil...
今天 00:12
Undervalued healthcare stocks with attractive valuation grades
Healthcare stocks continue to attract investor attention as managed care providers, pharmaceutical companies, biotechnology firms and healthcare services businesses navigate changing demand and indust...
09-16 01:15
Vertex trades higher after JPM gives bullish rating
Vertex Pharmaceuticals (VRTX) stock rose 1.6% premarket on Friday after J.P. Morgan moved to an Overweight rating for the company. The brokerage also set a December 2027 price target of $560 for the s...
09-11 21:30
CVS Health flags elevated medical expenses, sending managed care lower
Managed care stocks fell on Wednesday after CVS Health (CVS) said at the ongoing Wells Fargo Healthcare Conference that the company continues to face elevated medical costs, signaling that a major hea...
09-09 23:27
Revvity to acquire Human Cell Design
Revvity (RVTY) to acquire France-based Human Cell Design, a biotechnology company focused on human cell models for diabetes, obesity and other metabolic diseases. The financial terms were not disclose...
09-09 18:48
UnitedHealth sells interest in Optum Florida unit to TPG
UnitedHealth (UNH) is said to have sold an interest in some of its Optum Health operations in Florida to private equity company TPG as the health conglomerate is working to recover from a collapse in ...
09-09 12:59
Inhibrx cancer therapy outperforms Merck’s Keytruda in mid-stage trial
Inhibrx Biosciences (INBX) traded higher in the premarket on Tuesday after announcing that INBRX-106, its experimental therapy for head and neck cancer, outperformed pembrolizumab, Merck’s (MRK) block...
09-08 21:27
Three ways the midterms could move markets - BofA
The U.S. midterm elections are unlikely to amount to a true “regime change” for markets, but BofA strategist Michael Hartnett says the outcome could still produce sharply different reactions across st...
09-06 20:04
Healthcare August recap: Moderna jumps 156% as biotech shines; DaVita sinks
The healthcare sector (XLV) gained 4.91% in August, outperforming the broader S&P 500 (SPY), which advanced 2.68% during the month. Healthcare stocks benefited from strength in biotechnology and medic...
09-05 23:05
